ArticleTargeted oncology2024
Efficacy and Safety of Neoadjuvant Subcutaneous Envafolimab in dMMR/MSI-H Locally Advanced Colon Cancer.
Yuan Li et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleTargeted oncology2024
Yuan Li et al.PubMed ↗Publisher ↗
No numbers read from the abstract.